Status:
UNKNOWN
Develop the First Aid Medical Supplies for Hemostasis and Bacteriostasis With Clinical Trial
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Cesarean Section
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The current development of hemostatic and open wound infection care strategies will focus on enhancing the efficiency of hemostasis for internal bleeding, relieving pain, avoiding wound infection, and...
Detailed Description
This trial is performed when the subjects undergoing a cesarean section at Tri-Service General Hospital, Taipei, Taiwan (R.O.C). After disinfection of the surgical wound, regular gauze and chitosan dr...
Eligibility Criteria
Inclusion
- The subject is aged between 20 and 80 years old.
- Patients who need a cesarean section.
- The expected size of the wound is about 5 cm or more in length and 2 cm or more in width.
Exclusion
- Patients with a history of allergy to chitin components such as shrimp and crab.
- Patients with blood clotting disorders.
- Vulnerable groups.
- Patients with unstable signs of life.
Key Trial Info
Start Date :
May 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04884919
Start Date
May 10 2019
End Date
December 31 2021
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Defense of Medical Center, Tri-Service General Hospital
Taipei, Taiwan, 114